Suppr超能文献

有丝分裂活性:犬肿瘤评估方法学和预后价值的系统文献回顾。

Mitotic activity: A systematic literature review of the assessment methodology and prognostic value in canine tumors.

机构信息

University of Veterinary Medicine Vienna, Vienna, Austria.

Schwarzman Animal Medical Center, New York, NY.

出版信息

Vet Pathol. 2024 Sep;61(5):752-764. doi: 10.1177/03009858241239565. Epub 2024 Mar 27.

Abstract

One of the most relevant prognostic indices for tumors is cellular proliferation, which is most commonly measured by the mitotic activity in routine tumor sections. The goal of this systematic review was to analyze the methods and prognostic relevance of histologically measuring mitotic activity that have been reported for canine tumors in the literature. A total of 137 articles that correlated the mitotic activity in canine tumors with patient outcome were identified through a systematic (PubMed and Scopus) and nonsystematic (Google Scholar) literature search and eligibility screening process. Mitotic activity methods encompassed the mitotic count (MC, number of mitotic figures per tumor area) in 126 studies, presumably the MC (method not specified) in 6 studies, and the mitotic index (MI, number of mitotic figures per number of tumor cells) in 5 studies. A particularly high risk of bias was identified based on the available details of the MC methods and statistical analyses, which often did not quantify the prognostic discriminative ability of the MC and only reported values. A significant association of the MC with survival was found in 72 of 109 (66%) studies. However, survival was evaluated by at least 3 studies in only 7 tumor types/groups, of which a prognostic relevance is apparent for mast cell tumors of the skin, cutaneous melanoma, and soft tissue tumor of the skin and subcutis. None of the studies using the MI found a prognostic relevance. This review highlights the need for more studies with standardized methods and appropriate analysis of the discriminative ability to prove the prognostic value of the MC and MI in various tumor types. Future studies are needed to evaluate the influence of the performance of individual pathologists on the appropriateness of prognostic thresholds and investigate methods to improve interobserver reproducibility.

摘要

肿瘤最重要的预后指标之一是细胞增殖,通常通过常规肿瘤切片中的有丝分裂活性来衡量。本系统综述的目的是分析文献中已报道的用于犬肿瘤的组织学测量有丝分裂活性的方法及其预后相关性。通过系统(PubMed 和 Scopus)和非系统(Google Scholar)文献检索和资格筛选过程,共确定了 137 篇文章,这些文章将犬肿瘤的有丝分裂活性与患者结局相关联。有丝分裂活性方法包括 126 项研究中的有丝分裂计数(MC,肿瘤区域内有丝分裂图的数量)、6 项研究中的推测 MC(未指定方法)和 5 项研究中的有丝分裂指数(MI,肿瘤细胞数内有丝分裂图的数量)。根据 MC 方法和统计分析的可用细节,发现存在较高的偏倚风险,这些细节通常没有量化 MC 的预后区分能力,并且仅报告了 值。在 72 项研究中有丝分裂计数与生存显著相关(72/109,66%)。然而,仅在 7 种肿瘤类型/组中进行了至少 3 项研究的生存评估,其中皮肤肥大细胞瘤、皮肤黑色素瘤和皮肤和皮下软组织肿瘤的预后相关性明显。使用 MI 的研究均未发现预后相关性。本综述强调需要更多具有标准化方法和适当分析区分能力的研究,以证明 MC 和 MI 在各种肿瘤类型中的预后价值。未来的研究需要评估个别病理学家的表现对预后阈值的适当性的影响,并研究提高观察者间可重复性的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33a7/11370189/ecb4ee7fa181/10.1177_03009858241239565-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验